BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 6308029)

  • 1. Responsiveness of the hypophyseal-adrenocortical axis to corticotropin-releasing factor in pituitary-dependent Cushing's disease.
    Pieters GF; Hermus AR; Smals AG; Bartelink AK; Benraad TJ; Kloppenborg PW
    J Clin Endocrinol Metab; 1983 Sep; 57(3):513-6. PubMed ID: 6308029
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of repetitive administration of corticotropin-releasing hormone combined with lysine vasopressin on plasma adrenocorticotropin and cortisol levels in secondary adrenocortical insufficiency.
    Fukata J; Usui T; Tsukada T; Nakai Y; Koh T; Ishihara T; Tanaka I; Uchida K; Yoshimasa T; Nakano R
    J Clin Endocrinol Metab; 1990 Dec; 71(6):1624-31. PubMed ID: 2172283
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adrenocorticotropin- and cortisol-releasing effect of hexarelin, a synthetic growth hormone-releasing peptide, in normal subjects and patients with Cushing's syndrome.
    Ghigo E; Arvat E; Ramunni J; Colao A; Gianotti L; Deghenghi R; Lombardi G; Camanni F
    J Clin Endocrinol Metab; 1997 Aug; 82(8):2439-44. PubMed ID: 9253314
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pituitary microadenomas causing Cushing's disease respond to corticotropin-releasing factor.
    Orth DN; DeBold CR; DeCherney GS; Jackson RV; Alexander AN; Rivier J; Rivier C; Spiess J; Vale W
    J Clin Endocrinol Metab; 1982 Nov; 55(5):1017-9. PubMed ID: 6288750
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Corticotropin-releasing factor (CRF) stimulation test in normal subjects and patients with Cushing's syndrome.
    Zacharieva S; Matrosov P; Stoeva I; Kirilov G
    Exp Clin Endocrinol; 1989 Apr; 93(1):19-28. PubMed ID: 2544435
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The corticotropin-releasing factor stimulation test. An aid in the evaluation of patients with Cushing's syndrome.
    Chrousos GP; Schulte HM; Oldfield EH; Gold PW; Cutler GB; Loriaux DL
    N Engl J Med; 1984 Mar; 310(10):622-6. PubMed ID: 6319991
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Responsivity of adrenocorticotropin to corticotropin-releasing hormone and lack of suppressibility by dexamethasone are related phenomena in Cushing's disease.
    Hermus AR; Pieters GF; Pesman GJ; Smals AG; Benraad TJ; Kloppenborg PW
    J Clin Endocrinol Metab; 1986 Apr; 62(4):634-9. PubMed ID: 3005353
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FK 33-824, a met-enkephalin analog, blocks corticotropin-releasing hormone-induced adrenocorticotropin secretion in normal subjects but not in patients with Cushing's disease.
    Allolio B; Deuss U; Kaulen D; Leonhardt U; Kallabis D; Hamel E; Winkelmann W
    J Clin Endocrinol Metab; 1986 Dec; 63(6):1427-31. PubMed ID: 3023423
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The corticotropin-releasing hormone test in the postoperative evaluation of patients with cushing's syndrome.
    Avgerinos PC; Chrousos GP; Nieman LK; Oldfield EH; Loriaux DL; Cutler GB
    J Clin Endocrinol Metab; 1987 Nov; 65(5):906-13. PubMed ID: 3499448
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of synthetic corticotropin-releasing factor in normal individuals and in patients with hypothalamic-pituitary-adrenocortical disorders.
    Jørgensen H; Skare S; Frey H; Hanssen KF; Norman N
    Acta Med Scand; 1985; 218(1):79-84. PubMed ID: 2996312
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Corticotropin-releasing factor test in normal subjects and patients with hypothalamic-pituitary-adrenal disorders.
    Nakahara M; Shibasaki T; Shizume K; Kiyosawa Y; Odagiri E; Suda T; Yamaguchi H; Tsushima T; Demura H; Maeda T
    J Clin Endocrinol Metab; 1983 Nov; 57(5):963-8. PubMed ID: 6311867
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma ACTH and cortisol responses to TRF, vasopressin or hypoglycemia in cushing's disease and nelson's syndrome.
    Krieger DT; Luria M
    J Clin Endocrinol Metab; 1977 Feb; 44(2):361-8. PubMed ID: 190254
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Residual adrenocortical function after bilateral adrenalectomy for pituitary-dependent Cushing's syndrome.
    Kemink L; Hermus A; Pieters G; Benraad T; Smals A; Kloppenborg P
    J Clin Endocrinol Metab; 1992 Nov; 75(5):1211-4. PubMed ID: 1331164
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictive factors for initial cure and relapse rate after pituitary surgery for Cushing's disease.
    Pieters GF; Hermus AR; Meijer E; Smals AG; Kloppenborg PW
    J Clin Endocrinol Metab; 1989 Dec; 69(6):1122-6. PubMed ID: 2555381
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Corticotropin releasing factor: a new tool for the differential diagnosis of Cushing's syndrome.
    Müller OA; Stalla GK; von Werder K
    J Clin Endocrinol Metab; 1983 Jul; 57(1):227-9. PubMed ID: 6304135
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Responses to corticotropin-releasing hormone in the hypercortisolism of depression and Cushing's disease. Pathophysiologic and diagnostic implications.
    Gold PW; Loriaux DL; Roy A; Kling MA; Calabrese JR; Kellner CH; Nieman LK; Post RM; Pickar D; Gallucci W
    N Engl J Med; 1986 May; 314(21):1329-35. PubMed ID: 3010108
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A combined test using desmopressin and corticotropin-releasing hormone in the differential diagnosis of Cushing's syndrome.
    Newell-Price J; Perry L; Medbak S; Monson J; Savage M; Besser M; Grossman A
    J Clin Endocrinol Metab; 1997 Jan; 82(1):176-81. PubMed ID: 8989255
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of metyrapone pretreatment on adrenocorticotropin secretion induced by corticotropin-releasing hormone in normal subjects and patients with Cushing's disease.
    Totani Y; Niinomi M; Takatsuki K; Oiso Y; Tomita A
    J Clin Endocrinol Metab; 1990 Mar; 70(3):798-803. PubMed ID: 2155255
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The hypothalamic-pituitary-adrenal axis in critical illness: response to dexamethasone and corticotropin-releasing hormone.
    Reincke M; Allolio B; Würth G; Winkelmann W
    J Clin Endocrinol Metab; 1993 Jul; 77(1):151-6. PubMed ID: 8392081
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of pulsatile human corticotropin-releasing hormone administration on the adrenal insufficiency that follows cure of Cushing's disease.
    Avgerinos PC; Nieman LK; Oldfield EH; Loughlin T; Barnes KM; Loriaux DL; Cutler GB
    J Clin Endocrinol Metab; 1989 May; 68(5):912-6. PubMed ID: 2541160
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.